Status: Not yet recruiting
Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis
This study aims to explore a new therapeutic approach: the feasibility, safety and preliminary efficacy of directly spraying GM-CSF into the airway through bronchoscopy for the treatment of aPAP.
Participants needed: 10
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Jiuwu BaiUpdated: May 25, 2025
Eligibility criteria
Age: 18 to 60 years old;
Secondary PAP (such as secondary to blood diseases, etc.); [+8]